Skip to main content
. 2021 Apr 29;25:160. doi: 10.1186/s13054-021-03581-x

Table 1.

Patient characteristics of the entire study cohort before and after propensity-score matching

Variables Before matching After matching
Argatroban
n = 39
UFH
n = 465
SMD Argatroban
n = 39
UFH
n = 78
SMD p value
Age, years 55 (46; 61) 53 (40; 62) 0.197 55 (46; 61) 56 (48; 63) 0.096 0.538
Female patients 10 (26) 138 (30) 0.194 10 (26) 27 (35) 0.151 0.325
BMI, kg/m2 27.7 (24.9; 34.0) 27.8 (24.5; 33.0) 0.006 27.7 (24.9; 34.0) 29.2 (24.9; 33.2) 0.095 0.675
SOFA 12.0 (10.0; 15.0) 12.0 (9.0; 15.0) 0.124 12.0 (10.0; 15.0) 12.0 (9.0; 14.3) 0.153 0.354
ARDS subgroup 0.549 0.284 0.816
I: pulmonary 31 (79) 281 (60) 31 (79) 60 (77)
II: non-pulmonary 5 (13) 95 (20) 5 (13) 9 (11)
III: post-trauma 0 (0) 43 (9) 0 (0) 2 (3)
IV: mis-cellaneous 3 (8) 46 (10) 3 (8) 7 (9)
Days of ventilation before ECMO 1 (0; 2) 1 (1;4) 0.212 1 (0; 2) 1 (0; 2) 0.146 0.774
Resuscitation before ECMO 8 (21) 74 (16) 0.119 8 (21) 15 (19) 0.032 0.869
Days on ECMO support 11 (8; 16) 8 (6; 14) 0.349 11 (8; 16) 10 (6; 16) 0.086 0.303

Data are expressed as n (%), median (25. percentile; 75. percentile); miscellaneous includes drowning, pulmonary embolism, cystic fibrosis, and bridge to transplant; ARDS: acute respiratory distress syndrome; UFH: unfractionated heparin; SMD: standardized mean difference